Vaksin COVID-19 Oxford–AstraZeneca (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaksin COVID-19 Oxford–AstraZeneca" in Malay language version.

refsWebsite

Global rank Malay rank

9nih.gov

4^th place

14^th place

6doi.org

2^nd place

8^th place

4astrazeneca.com

low place

4bbc.co.uk

8^th place

33^rd place

4nytimes.com

7^th place

44^th place

3gov.uk

432^nd place

1,368^th place

3web.archive.org

1^st place

3ox.ac.uk

613^th place

898^th place

3worldcat.org

5^th place

23^rd place

3europa.eu

68^th place

197^th place

2wsj.com

79^th place

193^rd place

2statnews.com

8,771^st place

9,191^st place

2nbcnews.com

137^th place

734^th place

2thelancet.com

2,393^rd place

4,033^rd place

2tga.gov.au

3,984^th place

5,878^th place

2reuters.com

49^th place

98^th place

1canada.ca

1,712^th place

4,938^th place

1thehindu.com

52^nd place

493^rd place

1mfds.go.kr

low place

1srbija.gov.rs

low place

1cnn.com

28^th place

86^th place

1clinicaltrials.gov

5,225^th place

low place

1clinicaltrialsregister.eu

low place

1wikipedia.org

low place

1covid19vaccinetrial.co.uk

low place

1bloomberg.com

99^th place

160^th place

1khn.org

low place

1thehill.com

476^th place

6,102^nd place

1nasdaq.com

2,740^th place

2,323^rd place

1japantoday.com

3,795^th place

4,200^th place

1globo.com

62^nd place

846^th place

1nature.com

234^th place

260^th place

1harvard.edu

18^th place

46^th place

1semanticscholar.org

11^th place

67^th place

1theguardian.com

12^th place

84^th place

1cnbc.com

220^th place

521^st place

1bmj.com

1,226^th place

1,752^nd place

1ed.ac.uk

1,871^st place

5,596^th place

astrazeneca.com

"AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine". AstraZeneca (Siaran akhbar). 30 April 2020. Dicapai pada 13 January 2021.
"AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19" (Siaran akhbar). AstraZeneca. November 23, 2020. Dicapai pada 2021-01-05.
"AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19". AstraZeneca (Siaran akhbar). Dicapai pada 27 November 2020.
"FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial". AstraZeneca (Siaran akhbar). Dicapai pada 1 December 2020.

bbc.co.uk

"Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK". BBC News. BBC. 30 December 2020. Dicapai pada 30 December 2020.
"Covid: Brian Pinker, 82, first to get Oxford-AstraZeneca vaccine". BBC News. BBC. 4 January 2021. Dicapai pada 4 January 2021.
"Oxford/AstraZeneca Covid vaccine 'dose error' explained". BBC News. 27 November 2020. Dicapai pada 27 November 2020.
Triggle N (8 February 2021). "Covid: Are fears over Oxford-AstraZeneca jab justified?". BBC. Dicapai pada 9 February 2021.

bloomberg.com

"Covid Vaccine Front-Runner Is Months Ahead of Her Competition". Bloomberg Businessweek. 15 July 2020.

bmj.com

"Covid-19: First doses of vaccines in Scotland led to a substantial fall in hospital admissions". the BMJ. Dicapai pada 25 February 2021.

canada.ca

covid-vaccine.canada.ca

"Regulatory Decision Summary - AstraZeneca COVID-19 Vaccine". Health Canada. 26 February 2021. Dicapai pada 26 February 2021.

clinicaltrials.gov

"Investigating a Vaccine Against COVID-19". ClinicalTrials.gov (Registry). United States National Library of Medicine. 26 May 2020. NCT04400838. Diarkibkan daripada yang asal pada 11 October 2020. Dicapai pada 14 July 2020.

clinicaltrialsregister.eu

"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Diarkibkan daripada yang asal pada 5 October 2020. Dicapai pada 3 August 2020.

cnbc.com

Ellyatt H (8 February 2021). "AstraZeneca races to adapt Covid vaccine as South Africa suspends rollout" (dalam bahasa Inggeris). CNBC. Dicapai pada 8 February 2021.

cnn.com

edition.cnn.com

Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". CNN. São Paulo. Diarkibkan daripada yang asal pada 3 August 2020. Dicapai pada 3 August 2020.

covid19vaccinetrial.co.uk

"COVID-19 Vaccine Trials | COVID-19". covid19vaccinetrial.co.uk. Dicapai pada 11 April 2020.

doi.org

"A Phase III study to investigate a vaccine against COVID-19" (Registry). 26 May 2020. doi:10.1186/ISRCTN89951424. ISRCTN89951424. Cite journal requires |journal= (bantuan)
Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, dll. (2020). "Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects". Reviews in Medical Virology. n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Watanabe, Y.; Mendonça, L.; Allen, E. R.; Howe, A.; Lee, M.; Allen, J. D.; Chawla, H.; Pulido, D.; Donnellan, F.; Davies, H.; Ulaszewska, M.; Belij-Rammerstorfer, S.; Morris, S.; Krebs, A. S.; Dejnirattisai, W.; Mongkolsapaya, J.; Supasa, P.; Screaton, G. R.; Green, C. M.; Lambe, T.; Zhang, P.; Gilbert, S. C.; Crispin, M. (2021), "Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine", bioRxiv : The Preprint Server for Biology: 2021.01.15.426463, doi:10.1101/2021.01.15.426463, PMC 7836103, PMID 33501433
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). "SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway". Cell Research. 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.
Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature. 588 (7836): 16–18. Bibcode:2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278. S2CID 227156970.
Wise J (February 2021). "Covid-19: The E484K mutation and the risks it poses". BMJ. 372: n359. doi:10.1136/bmj.n359. PMID 33547053.

ed.ac.uk

"scotland first vaccine data preprint" (PDF). Dicapai pada 25 February 2021.

europa.eu

ema.europa.eu

"COVID-19 Vaccine AstraZeneca EPAR". European Medicines Agency (EMA).
"COVID-19 Vaccine AstraZeneca EPAR". European Medicines Agency (EMA).

ec.europa.eu

"European Commission authorises third safe and effective vaccine against COVID-19". European Commission (Siaran akhbar). Dicapai pada 29 January 2021.

globo.com

g1.globo.com

Voluntário brasileiro que participava dos testes da vacina de Oxford e morreu com a Covid era médico e ex-aluno da UFRJ, Globo

gov.uk

"Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Dicapai pada 4 January 2021.
"Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Dicapai pada 4 January 2021.
"Conditions of Authorisation for COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Dicapai pada 4 January 2021.

harvard.edu

ui.adsabs.harvard.edu

Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature. 588 (7836): 16–18. Bibcode:2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278. S2CID 227156970.

japantoday.com

"AstraZeneca resumes vaccine trial in talks with US". Japan Today. 3 October 2020.

khn.org

"They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma". Kaiser Health News. Dicapai pada 28 January 2021.

mfds.go.kr

"아스트라제네카社 코로나19 백신 품목허가". 식품의약품안전처 (dalam bahasa Korea). 식품의약품안전처. 10 February 2021. Dicapai pada 10 February 2021.

nasdaq.com

"AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch". RTTNews. Dicapai pada 15 July 2020.

nature.com

Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature. 588 (7836): 16–18. Bibcode:2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278. S2CID 227156970.

nbcnews.com

"'What's the deal?' Researchers in paused vaccine trial search for answers". NBC News.
"Volunteer in AstraZeneca Covid-19 vaccine trial dies in Brazil". NBC News.

nih.gov

pubmed.ncbi.nlm.nih.gov

Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, dll. (2020). "Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects". Reviews in Medical Virology. n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Watanabe, Y.; Mendonça, L.; Allen, E. R.; Howe, A.; Lee, M.; Allen, J. D.; Chawla, H.; Pulido, D.; Donnellan, F.; Davies, H.; Ulaszewska, M.; Belij-Rammerstorfer, S.; Morris, S.; Krebs, A. S.; Dejnirattisai, W.; Mongkolsapaya, J.; Supasa, P.; Screaton, G. R.; Green, C. M.; Lambe, T.; Zhang, P.; Gilbert, S. C.; Crispin, M. (2021), "Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine", bioRxiv : The Preprint Server for Biology: 2021.01.15.426463, doi:10.1101/2021.01.15.426463, PMC 7836103, PMID 33501433
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). "SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway". Cell Research. 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.
Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature. 588 (7836): 16–18. Bibcode:2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278. S2CID 227156970.
Wise J (February 2021). "Covid-19: The E484K mutation and the risks it poses". BMJ. 372: n359. doi:10.1136/bmj.n359. PMID 33547053.

ncbi.nlm.nih.gov

Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, dll. (2020). "Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects". Reviews in Medical Virology. n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Watanabe, Y.; Mendonça, L.; Allen, E. R.; Howe, A.; Lee, M.; Allen, J. D.; Chawla, H.; Pulido, D.; Donnellan, F.; Davies, H.; Ulaszewska, M.; Belij-Rammerstorfer, S.; Morris, S.; Krebs, A. S.; Dejnirattisai, W.; Mongkolsapaya, J.; Supasa, P.; Screaton, G. R.; Green, C. M.; Lambe, T.; Zhang, P.; Gilbert, S. C.; Crispin, M. (2021), "Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine", bioRxiv : The Preprint Server for Biology: 2021.01.15.426463, doi:10.1101/2021.01.15.426463, PMC 7836103, PMID 33501433
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). "SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway". Cell Research. 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.

nih.gov

"Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins". National Institutes of Health (NIH). 30 August 2020. Dicapai pada 1 September 2020.

nytimes.com

"Bill Gates, the Virus and the Quest to Vaccinate the World". The New York Times. 23 November 2020.
Wu KJ, Thomas K (8 September 2020). "AstraZeneca Pauses Vaccine Trial for Safety Review". The New York Times. ISSN 0362-4331. Dicapai pada 10 September 2020.
Grady D, Wu KJ, LaFraniere S (19 September 2020). "AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints". The New York Times. ISSN 0362-4331. Dicapai pada 22 September 2020.
Robbins R, Mueller B (25 November 2020). "After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine". The New York Times. ISSN 0362-4331. Dicapai pada 27 November 2020.

ox.ac.uk

"Oxford team to begin novel coronavirus vaccine research". University of Oxford. 2020-02-07. Dicapai pada 2020-11-28.
"Oxford team to begin novel coronavirus vaccine research". University of Oxford. Dicapai pada 2 January 2021.
"Oxford University breakthrough on global COVID-19 vaccine" (Siaran akhbar). University of Oxford. 23 November 2020. Dicapai pada 12 January 2021.

reuters.com

uk.reuters.com

"U.S. health secretary says AstraZeneca trial in United States remains on hold: CNBC". Reuters. 23 September 2020. Dicapai pada 24 September 2020.

reuters.com

Simões E, Burger L (22 October 2020). "AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue". Reuters. Dicapai pada 22 October 2020.

semanticscholar.org

api.semanticscholar.org

Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature. 588 (7836): 16–18. Bibcode:2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278. S2CID 227156970.

srbija.gov.rs

"150,000 doses of AstraZeneca vaccine arrive in Serbia". Government of Serbia. 21 February 2021. Dicapai pada 2 March 2021.

statnews.com

"AstraZeneca Covid-19 vaccine study is put on hold". Stat. 8 September 2020. Dicapai pada 10 September 2020.
"AstraZeneca Covid-19 vaccine study is put on hold". 8 September 2020.

tga.gov.au

"COVID-19 Vaccine AstraZeneca". Therapeutic Goods Administration (TGA). 16 February 2021. Dicapai pada 16 February 2021.

ebs.tga.gov.au

"TGA eBS - Product and Consumer Medicine Information Licence". www.ebs.tga.gov.au.

theguardian.com

Boseley S (26 November 2020). "Oxford/AstraZeneca vaccine to undergo new global trial". The Guardian. Dicapai pada 27 November 2020.

thehill.com

Coleman J (10 June 2020). "Final testing stage for potential coronavirus vaccine set to begin in July". The Hill. Dicapai pada 11 June 2020.

thehindu.com

"Already produced 40–50 million dosages of Covishield vaccine, says Serum Institute". The Hindu. 28 December 2020.

thelancet.com

"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet". Dicapai pada 9 December 2020.Templat:CC-notice
"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials". Findings. Dicapai pada 21 February 2021.

web.archive.org

Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". CNN. São Paulo. Diarkibkan daripada yang asal pada 3 August 2020. Dicapai pada 3 August 2020.
"Investigating a Vaccine Against COVID-19". ClinicalTrials.gov (Registry). United States National Library of Medicine. 26 May 2020. NCT04400838. Diarkibkan daripada yang asal pada 11 October 2020. Dicapai pada 14 July 2020.
"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Diarkibkan daripada yang asal pada 5 October 2020. Dicapai pada 3 August 2020.

wikipedia.org

en.wikipedia.org

"A Phase III study to investigate a vaccine against COVID-19" (Registry). 26 May 2020. doi:10.1186/ISRCTN89951424. ISRCTN89951424. Cite journal requires |journal= (bantuan)

worldcat.org

Wu KJ, Thomas K (8 September 2020). "AstraZeneca Pauses Vaccine Trial for Safety Review". The New York Times. ISSN 0362-4331. Dicapai pada 10 September 2020.
Grady D, Wu KJ, LaFraniere S (19 September 2020). "AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints". The New York Times. ISSN 0362-4331. Dicapai pada 22 September 2020.
Robbins R, Mueller B (25 November 2020). "After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine". The New York Times. ISSN 0362-4331. Dicapai pada 27 November 2020.

wsj.com

Strasburg J, Woo S (21 October 2020). "Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money". The Wall Street Journal.
Loftus P (13 September 2020). "AstraZeneca Covid-19 Vaccine Trials Resume in U.K.". The Wall Street Journal. Dicapai pada 13 September 2020.